In this session you'll learn:

• The pathophysiology of congestive heart failure
• Non-pharmacologic management options for congestive heart failure
• Guideline Directed Medical Therapy for heart failure with reduced and preserved ejection fraction

Arash Karnama, DO, FACOI, Associate Professor of Medicine and Interventional Cardiologist

Review of Non-Invasive Diagnosis in Coronary Artery Disease (2024)

Vikranth Gongidi, DO, FACOI, Cardiologist, Cleveland Clinic Indian River Medical Center

In this session you'll learn:

• Trends and drivers of increasing length of stay
• To identify clinical vs. operational opportunities in length of stay improvement
• To engage hospitalist teams for length of stay improvement

Beth J. Makowski Shell, DO, FACOI, Division Chief, Acute Care Medicine

In this session you will learn:

• What a fever of unknown origin is and how the definition has changed over the years
• The epidemiology, classifications, and diagnostic workup of the infectious and non-infectious fever of unknown origin
• Causes and cases of non-infectious fever of unknown origin, including treatment

Christian M. Chiavetta, DO, FACOI, Hospitalist, Internal Medicine Physician - Commonspirit Health, Dignity Health Medical Foundation

In this session you will:

• Review the current clinical definition and diagnostic criteria for osteoporosis
• Review FRAX® as one of the primary ways to calculate potential fragility fracture risk
• Review the current pharmacological treatment options for patients with osteoporosis
• Learn to recognize clinical aspects of fragility hip fractures as initial presentations of osteoporosis in many patients and the importance of postoperative medical management for secondary fracture prevention

Mikhail Signalov, DO, FACOI, Endocrinologist

In this session you'll learn:

• The basic types of hospital isolation
• Disease specific isolation policies and procedures
• About the duration of isolation and criteria to discontinue

Mia A. Taormina, DO, FACOI, Chair, Department of Infectious Disease, Duly Health and Care

In this session you will:

• Review the data regarding PICC line placement in higher risk individuals
• Review and discuss infections that typically require longer course intravenous antibiotics and the complexities of administering to individuals with IV drug abuse histories
• Discuss the data behind the use of long-course oral antibiotics as potential alternative treatment strategies for these infections

Mia A. Taormina, DO, FACOI, Chair, Department of Infectious Disease, Duly Health and Care

In this session you'll learn:

• To compare and contrast the 3 main rapid diagnostic tests
• To identify the application of rapid diagnostic tests in clinical scenarios
• To recognize that in the field of infectious diseases, biomarkers are biological surrogates of infection or predictors of certain outcomes

MarkAlain Déry, DO, MPH, FACOI (he/him/his), Chief Innovation Officer, Access Health Louisiana

In this session you will learn:

• Key concepts and terms pertaining to transgender and gender diverse identities
• The principles of creating respectful and inclusive clinical environment
• The principles of gender-affirming hormone therapy
• Key medical conditions and how they may impact transgender women and men

Danit Ariel, MD, MS, Clinical Assistant Professor of Medicine, Stanford University School of Medicine

In this session you'll learn:

• Key concepts and terms pertaining to transgender and gender diverse identities
• The principles of gender-affirming hormone therapy
• Approaches to management of gender-affirming hormones in patients admitted to the hospital

Ole-Petter R. Hamnvik, MD, Program Director, Endocrinology Fellowship, Brigham and Women's Hospital